Organism

Expert report details the scientific and regulatory challenges of genetic pest-control technologies

Retrieved on: 
Wednesday, November 8, 2023
Pest control, Council, Temperature, Organism, Health, Life, CCA, Western Ghats Ecology Expert Panel, Research, Risk assessment, Public, Safety, Investment, Uncertainty, Climate change, Agriculture

Genetic pest control — including the use of gene-editing tools to suppress pest populations or diminish their impacts — has spurred global research interest.

Key Points: 
  • Genetic pest control — including the use of gene-editing tools to suppress pest populations or diminish their impacts — has spurred global research interest.
  • In Canada, low research and development activity in genetic pest-control technologies could lead to a lack of preparedness for their impacts and their governance.
  • Framing Challenges and Opportunities for Canada provides an overview of the potential uses of genetic pest-control technologies, and articulates how their attendant risks might inform their responsible development, deployment, and oversight.
  • Visit www.cca-reports.ca to download the report, to learn more about the CCA and its assessments, or to join CCA's mailing list.

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

Retrieved on: 
Wednesday, May 3, 2023
Research, Technology, Clinical Trials, Software, Biotechnology, Pharmaceutical, Health, Science, Oncology, Artificial Intelligence, Doctor of Philosophy, Harvard T.H. Chan School of Public Health, Organism, Harvard University, Cancer, Dana–Farber Cancer Institute, Public health, Publication, Patient, Medicine, Harvard Department of Social Relations, Computational biology, Pharmaceutical industry, Biostatistics

Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors.

Key Points: 
  • Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors.
  • Prof. Michor is a professor of Computational Biology in the Department of Data Science at the Dana-Farber Cancer Institute, in the Department of Biostatistics at the Harvard T.H.
  • Chan School of Public Health, and in the Department of Stem Cell and Regenerative Biology at Harvard University.
  • “We are delighted to welcome Prof. Michor to our Board.

Launching consultations to modernize Canada's New Substances Notification Regulations (Organisms)

Retrieved on: 
Thursday, October 13, 2022
Interest, The Honourable, Health Canada, Canadian Environmental Protection Act, 1999, Risk assessment, Civilization, Agriculture, Virus, Organism, Indigenous self-government in Canada, Innovation, Science and Economic Development Canada, Animal, Yeast, Biotechnology, Fungus, Biofuel, Research, Aquaculture, Technology, Plant, PlaceSpeak, Climate change, CEPA, Environment, Economic development, Safety, Bacteria, Government, Biomanufacturing, Environment and Climate Change Canada, Human, Regulation, Risk management, Pharmaceutical industry, Health, Science, QC

That is why it is taking the necessary steps to modernize the New Substances Notification Regulations (Organisms) to make sure new living organisms created through, or used in, biotechnology are properly assessed before they can be introduced into the Canadian marketplace.

Key Points: 
  • That is why it is taking the necessary steps to modernize the New Substances Notification Regulations (Organisms) to make sure new living organisms created through, or used in, biotechnology are properly assessed before they can be introduced into the Canadian marketplace.
  • These consultations on modernizing our regulations will ensure we have a strong and flexible framework to address these ever-evolving technologies."
  • "It is time to update our New Substances Notification Regulations (Organisms) to better reflect our modern world.
  • Created in 2005, the New Substances Notification Regulations (Organisms) , under the Canadian Environmental Protection Act, 1999 (CEPA), is administered jointly by Environment and Climate Change Canada and Health Canada's New Substances Program.

Infectious Disease Expert Pardis Sabeti, M.D., Ph.D. Joins Board of The 221b Foundation

Retrieved on: 
Thursday, September 15, 2022
Institute, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Precision medicine, Engineering, Department, COVID-19, Infection, FDA, Disease, Center, CRISPR, Immunology, Ministry, Severe acute respiratory syndrome coronavirus 2, Health in Nepal, MIT, Intellectual property, IP, Harvard University, Cancer, History, Organism, CEO, Technology, Biology, Pardis, Public health, Board of directors, Foundation, Lassa fever, Diagnosis, Howard Hughes Medical Institute, Open philanthropy (doctrine), Board, PCR, Broad Institute, Pharmaceutical industry, Vaccine, Management

"CRISPR is uniquely suited to meet the global need for accurate, rapid and affordable diagnostic testing," said Bryan DeChairo, board member of The 221b Foundation and president and CEO of Sherlock Biosciences.

Key Points: 
  • "CRISPR is uniquely suited to meet the global need for accurate, rapid and affordable diagnostic testing," said Bryan DeChairo, board member of The 221b Foundation and president and CEO of Sherlock Biosciences.
  • Pardis has been a fierce global health advocate for her entire career, and will provide invaluable counsel as we deliver on our mission."
  • Through donations of equipment and resources, The 221b Foundation provided much needed support to help Nepal stem the spread of COVID-19 and bolster the countries testing strategy.
  • The Foundation provides global health partners with access to Sherlock Biosciences' products and IP through distribution and licensing.

Synthetic Biology Market worth $30.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, May 24, 2021
Articles, Branches of biology, Biology, Emerging technologies, Biotechnology, Nucleic acids, Synthetic biology, Molecular genetics, Oligonucleotide, Synthetic Genomics, DNA, Organism

However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.

Key Points: 
  • However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.
  • The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market in 2020.
  • On the basis of tool, the market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids.
  • In 2020, medical applications segment accounted for the largest share of synthetic biology market.

Synthetic Biology Market worth $30.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, May 24, 2021
Articles, Branches of biology, Biology, Emerging technologies, Biotechnology, Nucleic acids, Synthetic biology, Molecular genetics, Oligonucleotide, Synthetic Genomics, DNA, Organism

However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.

Key Points: 
  • However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market.
  • The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market in 2020.
  • On the basis of tool, the market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids.
  • In 2020, medical applications segment accounted for the largest share of synthetic biology market.

Global Plant Biostimulants Markets, 2020-2027 - Biostimulants Business Remain Buoyant amid COVID-19 Disruptions

Retrieved on: 
Wednesday, December 30, 2020
Microorganism, Organism, Bacteria

The global market for Plant Biostimulants is forecast to reach US$4.5 billion by the year 2027, trailing a post COVID-19 CAGR of 10.2% over the analysis period 2020 through 2027.

Key Points: 
  • The global market for Plant Biostimulants is forecast to reach US$4.5 billion by the year 2027, trailing a post COVID-19 CAGR of 10.2% over the analysis period 2020 through 2027.
  • This goal comes against the backdrop of the challenges involved in feeding a growing global population.
  • Natural biostimulants are an emerging group of plant biostimulants defined as the use of microorganism such as fungi and bacteria.
  • Bacteria, fungi and yeasts have the ability to promote plant growth by enabling biocontrol of plant pathogen that retard growth.

Europe Yeast Extract Market (2020 to 2026) - by Technology, Application, Form and Country - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 3, 2020
Retail, Other Retail, Food and drink, Foods, Leavening agents, Yeasts, Fermentation in food processing, Edible fungi, Food additives, Baker's yeast, Saccharomyces cerevisiae, Microorganism, Ethanol, Organism

Yeast is an example of a eukaryotic single-celled microorganism that is classified as one of the members of the fungi kingdom.

Key Points: 
  • Yeast is an example of a eukaryotic single-celled microorganism that is classified as one of the members of the fungi kingdom.
  • Baker's yeast is useful in the manufacturing of ethanol production, baked products, and antibiotics for medical uses.
  • Yeast extract is the common name for thick brown partly solid processed yeast products that are obtained from extracts of the cell content.
  • The consequence of this process is yeast extract, a blend of different carbohydrates, minerals, amino acids, and vitamins.

New book aims to help corporations evolve

Retrieved on: 
Tuesday, September 8, 2020
Biology, Organism

Sirkin returns to the corporate world in this new, second edition of an earlier book, with updated contents for current times.

Key Points: 
  • Sirkin returns to the corporate world in this new, second edition of an earlier book, with updated contents for current times.
  • Organizations, including corporations, are living entities and as such, they behave much the same as any biological organism, Sirkin says.
  • In The Secret Life of Corporations, Sirkin views corporations as living, functional organisms.
  • Sirkin hopes that his book will help corporate leaders realize that they must evolve with their organizations in order to survive in the business world, much like organisms evolve to survive in the wild.

Scientists Identify Genome-Wide Traits Associated with Microbial Growth Strategy and Ecosystem Nutrient Status

Retrieved on: 
Tuesday, February 18, 2020
Biology, Systems ecology, Natural sciences, Nature, Ecosystem, Superorganisms, Symbiosis, Mesocosm, DNA, Organism

Whole mixed microbial communities from the both fertilized and unfertilized mesocosms were collected and their DNA sequenced.

Key Points: 
  • Whole mixed microbial communities from the both fertilized and unfertilized mesocosms were collected and their DNA sequenced.
  • Typically, scientists would then catalog the genes in the samples, predict what organisms they came from, and what they do.
  • The question is whether these basic traits could be turned into a metric for ecosystem nutrient status."
  • These modern profiles of ecosystem growth will then be extrapolated into geological history using biogeochemical modeling.